| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/07/1998 | EP0815216A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 01/07/1998 | EP0815142A1 Antigen composition against mycoplasma |
| 01/07/1998 | EP0815132A1 Leptospiral outer membrane proteins |
| 01/07/1998 | EP0815127A1 Fucopeptides |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0815124A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/07/1998 | EP0815084A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
| 01/07/1998 | EP0814839A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 01/07/1998 | EP0814829A1 Method for enhancing the antibody response to specific antigens with interleukin-10 |
| 01/07/1998 | EP0814825A1 Method of treating or preventing non-viral microbial infection |
| 01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 01/07/1998 | EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/07/1998 | EP0814812A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 01/07/1998 | EP0814776A1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 01/07/1998 | EP0814661A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 01/07/1998 | EP0814660A1 Topical antimicrobial agents |
| 01/07/1998 | EP0778847A4 Immunostimulatory agents |
| 01/07/1998 | EP0713527A4 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 01/07/1998 | EP0673370B1 Tropone-substituted phenyloxazolidinone antibacterial agents |
| 01/07/1998 | EP0656888B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/07/1998 | EP0542795B1 Tnf inhibitors |
| 01/07/1998 | EP0539442B1 Enzyme inactivators |
| 01/07/1998 | EP0482071B1 New antiviral agents |
| 01/07/1998 | CN1169729A Modulators functions of FAS/APOL receptors |
| 01/07/1998 | CN1169727A Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity |
| 01/07/1998 | CN1169433A Carbohydrate derivatives |
| 01/06/1998 | US5705647 Intermediates for making HIV-protease inhibitors |
| 01/06/1998 | US5705645 Hereroaryl derivatives of monocyclic beta-lactam antibiotics |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705612 NEF peptide encoded by human immunodefiency virus type 1 (HIV-1) |
| 01/06/1998 | US5705522 Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors |
| 01/06/1998 | US5705500 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/06/1998 | US5705499 Viricides |
| 01/06/1998 | US5705492 3'-O-aminoacyl ARA uridines, method of making, and antiviral activity |
| 01/06/1998 | US5705367 Neisseria having reading frames |
| 01/06/1998 | US5705361 Hybrid transposon with PT operon, plasmids and bacterial strains therefor |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 01/06/1998 | US5705161 Immunogenic meningococcal LPS and other membrane vesicles and vaccine therefrom |
| 01/06/1998 | US5705158 Kits with antileukocyte antibody conjugates |
| 01/06/1998 | CA2033814C Inhibitor of the proliferation of herpesviruses and inhibitor of the recurrence of affections caused by their latent infection |
| 12/31/1997 | WO1997049825A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 12/31/1997 | WO1997049812A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049670A1 New synthetic catechol derivatives, method for production and use thereof |
| 12/31/1997 | WO1997049416A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | WO1997049413A1 Ionic polymers as anti-infective agents |
| 12/31/1997 | WO1997049411A1 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv |
| 12/31/1997 | WO1997049373A2 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin |
| 12/31/1997 | CN1169142A Compound for inhibition of gastric acid secretion |
| 12/31/1997 | CN1169137A Improved synthesis of cyclopropylacetylene |
| 12/31/1997 | CN1168891A Method for preparing chelate of antibiotic and complex metallic salt |
| 12/31/1997 | CN1036849C Method for prepn. of anti-viral compounds |
| 12/31/1997 | CN1036838C Method for prepn. of vaccine |
| 12/31/1997 | CA2259636A1 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | CA2259344A1 Ionic polymers comprising an amino or ammonium group as anti-infective agents |
| 12/31/1997 | CA2258956A1 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv |
| 12/31/1997 | CA2258168A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | CA2252809A1 New synthetic catechol derivatives, method for production and use thereof |
| 12/30/1997 | US5703243 Intermediates for pyrrolidylthiocarbapenem derivative |
| 12/30/1997 | US5703236 Tetrahydrofuran antifungals |
| 12/30/1997 | US5703231 Process for making antimicrobial compounds |
| 12/30/1997 | US5703230 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 12/30/1997 | US5703103 Thiazolylpyrazolinones and their use for protecting technical materials |
| 12/30/1997 | US5703098 Inhibitors of cytokines including tumor necrosis factor |
| 12/30/1997 | US5703094 Quinolone- and naphthyridonecarboxylic acid derivatives |
| 12/30/1997 | US5703079 Tetrahydrofuran antifungals |
| 12/30/1997 | US5703069 Method for inhibiting and controlling viral growth |
| 12/30/1997 | US5703068 Penem compounds |
| 12/30/1997 | US5703058 Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
| 12/30/1997 | US5703038 Emhanced biological activity |
| 12/30/1997 | US5702934 Processes for producing an enzyme |
| 12/30/1997 | CA2102282C Polymeric antimicrobials and their use in pharmaceutical compositions |
| 12/30/1997 | CA1339609C 2-substituted-4-substituted-1, 3-dioxolanes, synthesis and use thereof |
| 12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
| 12/29/1997 | EP0814086A1 Antibiotics tkr1912-i and tkr1912-ii and process for producing the same |
| 12/29/1997 | EP0814080A1 Squalene synthetase inhibitors |
| 12/29/1997 | EP0813868A2 Retroviral protease inhibitors |
| 12/29/1997 | EP0813867A2 Retroviral protease inhibitors |
| 12/29/1997 | EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 12/29/1997 | EP0813543A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 12/29/1997 | EP0813542A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 12/29/1997 | EP0813539A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 12/29/1997 | EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 12/29/1997 | EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/29/1997 | EP0813519A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 12/29/1997 | EP0813422A1 Compositions and methods for stimulating antibody class switching |
| 12/29/1997 | EP0813419A1 Modulators of regulatory proteins |
| 12/29/1997 | EP0705270B1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 12/29/1997 | EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 12/29/1997 | EP0603303B1 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent |
| 12/29/1997 | EP0569564B1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors |
| 12/24/1997 | WO1997048822A1 Screening methods using microbial strain pools |
| 12/24/1997 | WO1997048691A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 12/24/1997 | WO1997048482A1 Iodinated matrices for disinfecting biological fluids |
| 12/24/1997 | WO1997048417A1 Vaccine to prevent streptococcal endocarditis |
| 12/24/1997 | WO1997048389A1 2-cyclopenten-1-one as an inducer of hsp70 |
| 12/24/1997 | WO1997042941A3 Buccal delivery system |
| 12/24/1997 | WO1997040006A3 Phosphate mimics |
| 12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |